These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25039715)

  • 1. The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study.
    Reich KM; Chang HJ; Rezaie A; Wang H; Goodman KJ; Kaplan GG; Svenson LW; Lees G; Fedorak RN; Kroeker KI
    Aliment Pharmacol Ther; 2014 Sep; 40(6):629-38. PubMed ID: 25039715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study.
    Kaplan GG; Seow CH; Ghosh S; Molodecky N; Rezaie A; Moran GW; Proulx MC; Hubbard J; MacLean A; Buie D; Panaccione R
    Am J Gastroenterol; 2012 Dec; 107(12):1879-87. PubMed ID: 23165448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada.
    Moore SE; McGrail KM; Peterson S; Raval MJ; Karimuddin AA; Phang PT; Bressler B; Brown CJ
    Dis Colon Rectum; 2014 Jan; 57(1):83-90. PubMed ID: 24316950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.
    Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1301-9. PubMed ID: 22506582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
    Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?
    Schluender SJ; Ippoliti A; Dubinsky M; Vasiliauskas EA; Papadakis KA; Mei L; Targan SR; Fleshner PR
    Dis Colon Rectum; 2007 Nov; 50(11):1747-53. PubMed ID: 17704969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL; Jewell DP; Travis SP
    Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab.
    Taxonera C; Estellés J; Fernández-Blanco I; Merino O; Marín-Jiménez I; Barreiro-de Acosta M; Saro C; García-Sánchez V; Gento E; Bastida G; Gisbert JP; Vera I; Martinez-Montiel P; Garcia-Morán S; Sánchez MC; Mendoza JL
    Aliment Pharmacol Ther; 2011 Feb; 33(3):340-8. PubMed ID: 21133961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.
    Su C; Salzberg BA; Lewis JD; Deren JJ; Kornbluth A; Katzka DA; Stein RB; Adler DR; Lichtenstein GR
    Am J Gastroenterol; 2002 Oct; 97(10):2577-84. PubMed ID: 12385442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
    Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
    World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
    Monterubbianesi R; Aratari A; Armuzzi A; Daperno M; Biancone L; Cappello M; Annese V; Riegler G; Orlando A; Viscido A; Meucci G; Gasbarrini A; Guidi L; Lavagna A; Sostegni R; Onali S; Papi C; Kohn A;
    J Crohns Colitis; 2014 Aug; 8(8):852-8. PubMed ID: 24472490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.
    Gustavsson A; Järnerot G; Hertervig E; Friis-Liby I; Blomquist L; Karlén P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Magnuson A; Halfvarson J; Tysk C
    Aliment Pharmacol Ther; 2010 Oct; 32(8):984-9. PubMed ID: 20937043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does anti-TNF therapy reduce the requirement for surgery in ulcerative colitis? A systematic review.
    Filippi J; Allen PB; Hébuterne X; Peyrin-Biroulet L
    Curr Drug Targets; 2011 Sep; 12(10):1440-7. PubMed ID: 21466486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patients.
    Costello SP; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; O'Connor S; Connor SJ; Sparrow MP; Bampton P; Walsh AJ; Andrews JM;
    Intern Med J; 2015 Jun; 45(6):659-66. PubMed ID: 25732268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of severe ulcerative colitis.
    Caprilli R; Viscido A; Latella G
    Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):92-101. PubMed ID: 17268544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operative strategy modifies risk of pouch-related outcomes in patients with ulcerative colitis on preoperative anti-tumor necrosis factor-α therapy.
    Gu J; Remzi FH; Shen B; Vogel JD; Kiran RP
    Dis Colon Rectum; 2013 Nov; 56(11):1243-52. PubMed ID: 24104999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology predictors of medically refractory ulcerative colitis.
    Melson JE; Giusto D; Kwasny M; Eichenseer P; Jakate S; Keshavarzian A
    Dis Colon Rectum; 2010 Sep; 53(9):1280-6. PubMed ID: 20706071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.